139
Views
14
CrossRef citations to date
0
Altmetric
Review

Cysteinyl leukotriene receptor CysLT1 as a novel therapeutic target for allergic rhinitis treatment

, MD, PhD
Pages 415-423 | Published online: 18 Mar 2008

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Tomoko Hommura, Katsuaki Dan, Sho Kanzaki, Kenji Watanabe & Kaoru Ogawa. (2019) Evaluation of the therapeutic potential and underlying mechanisms of synephrine, a component of Kampo medicine, against allergic rhinitis. Cogent Biology 5:1.
Read now
Smita Agarwal, Gorla Venkateswara Reddy & Pallu Reddanna. (2009) Eicosanoids in inflammation and cancer: the role of COX-2. Expert Review of Clinical Immunology 5:2, pages 145-165.
Read now

Articles from other publishers (12)

Na Wang, Xinheng He, Jing Zhao, Hualiang Jiang, Xi Cheng, Yu Xia, H. Eric Xu & Yuanzheng He. (2022) Structural basis of leukotriene B4 receptor 1 activation. Nature Communications 13:1.
Crossref
Xiaojun Hu, Junjie Mao, Bin Zhou, Huitao Zhang, Bing Li, Pengfei Pang & Hong Shan. (2019) Generation and phenotype analysis of CysLTR1 L118F mutant mice. Journal of Cellular Biochemistry 121:3, pages 2372-2384.
Crossref
Hideaki Shirasaki, Etsuko Kanaizumi & Tetsuo Himi. (2017) Leukotriene D 4 induces chemotaxis in human eosinophilc cell line, EoL-1 cells via CysLT1 receptor activation. Heliyon 3:11, pages e00464.
Crossref
Hideaki Shirasaki, Etsuko Kanaizumi & Tetsuo Himi. (2017) Expression and localization of GPR99 in human nasal mucosa. Auris Nasus Larynx 44:2, pages 162-167.
Crossref
Yusuke Okuma, Yoshitaka Okamoto, Syuji Yonekura, Tomohisa Iinuma, Toshioki Sakurai, Sawako Hamasaki, Yuji Ohki, Heizaburo Yamamoto & Daiju Sakurai. (2016) Persistent nasal symptoms and mediator release after continuous pollen exposure in an environmental challenge chamber. Annals of Allergy, Asthma & Immunology 117:2, pages 150-157.
Crossref
Hideaki Shirasaki, Etsuko Kanaizumi, Nobuhiko Seki & Tetsuo Himi. (2015) Leukotriene E4 induces MUC5AC release from human airway epithelial NCI-H292 cells. Allergology International 64:2, pages 169-174.
Crossref
Hideaki Shirasaki, Etsuko Kanaizumi, Nobuhiko Seki, Manabu Fujita, Megumi Kikuchi & Tetsuo Himi. (2013) Localization and Up-Regulation of Cysteinyl Leukotriene-2 Receptor in Human Allergic Nasal Mucosa. Allergology International 62:2, pages 223-228.
Crossref
CHERYL A. GRICE, ANNE M. FOURIE & ALICE LEE-DUTRA. 2012. Anti-Inflammatory Drug Discovery. Anti-Inflammatory Drug Discovery 58 103 .
Liefeng Wang, Changsheng Du, Jie Lv, Wei Wei, Ye Cui & Xin Xie. (2011) Antiasthmatic Drugs Targeting the Cysteinyl Leukotriene Receptor 1 Alleviate Central Nervous System Inflammatory Cell Infiltration and Pathogenesis of Experimental Autoimmune Encephalomyelitis. The Journal of Immunology 187:5, pages 2336-2345.
Crossref
Ilaria Bettinelli, Davide Graziani, Cristina Marconi, Alessandro Pedretti & Giulio Vistoli. (2011) The Approach of Conformational Chimeras to Model the Role of Proline-Containing Helices on GPCR Mobility: the Fertile Case of Cys-LTR1. ChemMedChem 6:7, pages 1217-1227.
Crossref
Rui Zhao, Wen-Zhen Shi, Yong-Mei Zhang, San-Hua Fang & Er-Qing Wei. (2011) Montelukast, a cysteinyl leukotriene receptor-1 antagonist, attenuates chronic brain injury after focal cerebral ischaemia in mice and rats. Journal of Pharmacy and Pharmacology 63:4, pages 550-557.
Crossref
. (2011) . Nihon Bika Gakkai Kaishi (Japanese Journal of Rhinology) 50:1, pages 108-109.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.